Epitome Biosystems EpiTag™ Technology

WideScreen™ EpiTag™ Assays Overview Technology ERK Data Available Assays WideScreen™ RTK Assays RTK Assays RTK Data Available Assays WideScreen™ Biomarker Assays Human Cancer Panel 1 (Tumor Markers) Human Cancer Panel 2 (Growth Factors) Human CVD Panel 1 (Apolipoprotein) Human CVD Panel 2 (Inflammation) Human CVD Panel 3 Human CVD Panel 4 Human CVD Panel 5 (Acute Phase) Human CVD Panel 6

Advanced bioinformatics is employed to identify proteolytic fragments of target proteins that contain two or more unique regions, or EpiTag™ Sequences. Antibodies against the EpiTag Sequences are used as capture and detection reagents to form sandwich immunoassays. Synthetic peptides that represent the targeted fragment are used as standards.

For more details, visit Epitome Biosystems.
EpiTag™ Technology and Assays are offered under limited, non-transferable license from Epitome Biosystems, Inc.